New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 17, 2018 - Shire announced the FDA approval of Motegrity (prucalopride), for the treatment of chronic idiopathic constipation (CIC) in adults.
Download PDF
Return to publications
